Novo Nordisk to acquire Forma Therapeutics in $1.1bn deal
The acquisition will complement Novo Nordisk’s strategy to focus on haemoglobinopathies, a group of disorders characterised by abnormal…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Sep 22
The acquisition will complement Novo Nordisk’s strategy to focus on haemoglobinopathies, a group of disorders characterised by abnormal…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
02 Sep 22
After having taken place on a completely digital platform due to the pandemic in 2020, the MEDICA LABMED…
02 Sep 22
New Hampshire accused J&J of promoting opioids to physicians and patients lying about how addictive they were when…
01 Sep 22
Pfizer and BioNTech’s bivalent Covid-19 vaccine is authorised as single booster dose for adults and adolescents aged 12…
01 Sep 22
The approval is based on the data from ASCEND and ASCEND-Peds trials, in which Xenpozyme showed improvement in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Aug 22
The EC approval is based on results from Phase 3 ASCEMBL trial, in which Scemblix nearly doubled the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Aug 22
Patients receiving treatment with cemdisiran experienced clinically significant decreases in their 24-hour urine protein to creatinine ratio when…
29 Aug 22
If approved, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be commercially available in the European Union…
29 Aug 22
According to the data, Farxiga continues to provide clinically significant advantages to patients with heart failure regardless of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Aug 22
The approval was given by the Japanese Ministry of Health, Labour, and Welfare after assessing the findings of…